What's breaking now, across thousands of outlets.
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
MSMER-2023 withdrawal removes overlapping procedures, eliminates duplication, says NMC; medical activists say the move dilutes regulatory oversight, will ultimately put patients at risk
Federal Government has said genomic analysis of the confirmed Ebola Virus Disease case in the Federal Capital Territory, FCT, showed the virus is genetically related to the virus identified in a case…
The Bayelsa State Government has said there is no confirmed case of Ebola in the state, assuring residents that measures are being taken to prevent its spr Read More…
MADRID — Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi slashed the chances of dying by 58% versus Imfinzi alone in the first-line maintenance setting in certain small cell lung cancer…
The Lagos State Government has intensified its preparedness efforts following Nigeria’s confirmation of an imported case of Ebola disease in the Federal Capital Territory, FCT, assuring residents that…
